• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Bloom Energy Group Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

    7/17/24 6:03:31 AM ET
    $ADVM
    $APVO
    $ASML
    $ASST
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Get the next $ADVM alert in real time by email

    Shares of Bloom Energy Corporation (NYSE:BE) rose sharply in today's pre-market trading after the company announced a strategic partnership with CoreWeave.

    Bloom Energy said it entered into a partnership to deploy its proprietary fuel cells to generate on-site power for CoreWeave at a high-performance data center in Illinois.

    Bloom Energy shares jumped 12.1% to $16.90 in pre-market trading.

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Shimmick Corporation (NASDAQ:SHIM) gained 53% to $3.09 in pre-market trading after the company received a $27.6 million subcontract for the Sunol Valley Water Treatment Plant Ozonation Project.
    • Aptevo Therapeutics Inc. (NASDAQ:APVO) shares rose 39.3% to $0.46 in pre-market trading after surging around 10% on Tuesday. Aptevo Therapeutics recently announced closing of $2.75 million offering.
    • MicroAlgo Inc. (NASDAQ:MLGO) shares rose 26.1% to $3.58 in pre-market trading after declining around 14% on Tuesday.
    • Conduit Pharmaceuticals Inc. (NASDAQ:CDT) rose 16.1% to $0.2916 in pre-market trading. Conduit Pharmaceuticals shares gained around 5% on Tuesday after the company announced it received patent approval for its lead asset targeting autoimmune diseases..
    • Adverum Biotechnologies, Inc. (NASDAQ:ADVM) shares gained 15.5% to $10.31 in pre-market trading. Adverum Biotechnologies revealed 26-week interim analysis results of Ixo-vec from LUNA Phase 2 trial at 2024 ASRS Annual Meeting.
    • GitLab Inc. (NASDAQ:GTLB) gained 13.9% to $57.71 in pre-market trading after Reuters reported that the company is exploring a sale.
    • Asset Entities Inc. (NASDAQ:ASST) shares climbed 12.6% to $1.77 in pre-market trading.
    • Immersion Corporation (NASDAQ:IMMR) shares surged 12.4% to $13.69 in pre-market trading after gaining over 5% on Tuesday.
    • CERo Therapeutics Holdings, Inc. (NASDAQ:CERO) shares gained 7.7% to $0.21 in pre-market trading.

    Losers

    • Cineverse Corp (NASDAQ:CNVS) shares fell 15.6% to $0.75 in pre-market trading.
    • Logistic Properties of the Americas (NYSE:LPA) shares fell 15.2% to $22.04 in pre-market trading after jumping 69% on Tuesday.
    • Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX) shares fell 15.2% to $1.28 in pre-market trading after jumping 41% on Tuesday.
    • Five Below, Inc. (NASDAQ:FIVE) shares declined 14.7% to $87.00 in pre-market trading after the company announced a CEO transition. Additionally, comparable sales decreased in the 10-week period ended July 13.
    • Safe and Green Development Corporation (NASDAQ:SGD) shares dipped 11% to $0.3642 in pre-market trading.
    • Silo Pharma, Inc. (NASDAQ:SILO) shares fell 9.2% to $2.17 in pre-market trading. Silo Pharma shares jumped 123% on Tuesday after the company obtained an exclusive global license to develop, manufacture, and commercialize its Alzheimer’s drug.
    • Eightco Holdings Inc. (NASDAQ:OCTO) shares fell 8.7% to $0.48 in pre-market trading. Eightco Holdings recently said first-quarter revenue fell to $9.6 million from $15.9 million in the year-ago period.
    • Cerus Corporation (NASDAQ:CERS) fell 8.4% to $2.19 in pre-market trading. On July 2, Cerus announced the appointment of Dean Gregory to its Board of Directors.
    • Siebert Financial Corp. (NASDAQ:SIEB) fell 6.8% to $1.77 in pre-market trading after gaining over 9% on Tuesday.
    • ASML Holding N.V.  (NASDAQ:ASML) shares declined 6.8% to $995.90 in pre-market trading. ASML reported better-than-expected second-quarter earnings, driven by robust sales in China and a surge in new bookings.

    Now Read This:

    • Jim Cramer Says If You Sell This Chinese EV Stock Now, ‘Some Clown’ Will Be ‘Real Positive About It,’ Wait Until ‘All That Stuff Happens’
    Get the next $ADVM alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADVM
    $APVO
    $ASML
    $ASST

    CompanyDatePrice TargetRatingAnalyst
    GitLab Inc.
    $GTLB
    1/7/2026$40.00Overweight → Neutral
    Cantor Fitzgerald
    ASML Holding N.V. New York Registry Shares
    $ASML
    1/5/2026$1528.00Mkt Perform → Outperform
    Bernstein
    Shimmick Corporation
    $SHIM
    1/5/2026$6.00Hold → Buy
    Craig Hallum
    GitLab Inc.
    $GTLB
    12/17/2025$52.00Buy
    BTIG Research
    GitLab Inc.
    $GTLB
    12/16/2025Overweight → Sector Weight
    KeyBanc Capital Markets
    Five Below Inc.
    $FIVE
    12/8/2025$216.00Hold → Buy
    Truist
    Five Below Inc.
    $FIVE
    12/4/2025$170.00 → $195.00Outperform
    Telsey Advisory Group
    GitLab Inc.
    $GTLB
    12/3/2025$40.00Outperform → Neutral
    Macquarie
    More analyst ratings

    $ADVM
    $APVO
    $ASML
    $ASST
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Information Officer Jhunjhunwala Amit covered exercise/tax liability with 312 shares, decreasing direct ownership by 1% to 24,430 units (SEC Form 4)

    4 - FIVE BELOW, INC (0001177609) (Issuer)

    1/6/26 4:28:13 PM ET
    $FIVE
    Department/Specialty Retail Stores
    Consumer Discretionary

    Chief Executive Officer Staples William bought $124,750 worth of shares (3,276 units at $38.08), increasing direct ownership by 0.96% to 345,671 units (SEC Form 4)

    4 - Gitlab Inc. (0001653482) (Issuer)

    1/5/26 6:26:25 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Interim CFO Shen James sold $96,647 worth of shares (2,538 units at $38.08), decreasing direct ownership by 5% to 52,284 units (SEC Form 4)

    4 - Gitlab Inc. (0001653482) (Issuer)

    1/5/26 6:25:59 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $APVO
    $ASML
    $ASST
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Cineverse Acquires Giant Worldwide and Integrates Service into Matchpoint™ Platform, Bringing Deep Studio Relationships into Its Automated Media Services Ecosystem

    Acquisition Brings Giant's Existing Clients – Including the World's Top Movie Studios, Networks and Leading Entertainment Companies – to Cineverse's Matchpoint™ Ecosystem LOS ANGELES, Jan. 7, 2026 /PRNewswire/ -- Cineverse (NASDAQ:CNVS), a next-generation entertainment studio, today announced the acquisition of Giant Worldwide, a global media services provider serving the world's leading Hollywood studios and streaming platforms. Thanks to this strategic acquisition, Matchpoint™—the Company's award-winning, AI-powered media supply chain solution—solidifies its role as the lea

    1/7/26 11:00:00 AM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    CERo Therapeutics Provides Clinical Update on Phase 1 Trial of CER-1236 in AML (CertainT-1) Highlighting Key Safety Data and Platelet Transfusion–Free Interval Observed in a Patient with Myelodysplastic Syndrome/AML

    Company to host analyst call at 5:00pm ET today to discuss progress to date and expansion of clinical trial SOUTH SAN FRANCISCO, Calif, Jan. 07, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (OTCQB:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanisms, announces a key clinical update from the Company's ongoing CertainT-1 trial focused on patients with acute myeloid leukemia (AML). Following completion of the dose-limiting toxicity (DLT) observation period for the first cohort, investigators observed cell expansion with no CRS, ICANS, or treatment-related adverse events reported to date. Expansion w

    1/7/26 9:09:00 AM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    RenX Enterprises Completes Purchase of Komptech Crambo Shredder and Diamond Z Horizontal Grinder Following Strong Operating Performance

    MIAMI, FL, Jan. 07, 2026 (GLOBE NEWSWIRE) -- RenX Enterprises, Inc. (the "Company") (NASDAQ:RENX), formerly known as Safe and Green Development Corporation, today announced that it has completed the purchase of a Komptech Crambo shredder and a Diamond Z horizontal grinder that had previously been deployed under a rental arrangement. The Company elected to acquire the equipment following a review of operating results demonstrating increased throughput, improved processing efficiency, and incremental revenue contribution during the rental period. A photograph of the Company's Diamond Z horizontal grinder currently operating within RenX's materials processing operations is included below. Di

    1/7/26 8:45:00 AM ET
    $RENX
    $SGD
    Real Estate
    Finance

    $ADVM
    $APVO
    $ASML
    $ASST
    SEC Filings

    View All

    GitLab Inc. filed SEC Form 8-K: Leadership Update

    8-K - Gitlab Inc. (0001653482) (Filer)

    1/5/26 4:00:17 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Strive Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events

    8-K - Strive, Inc. (0001920406) (Filer)

    1/5/26 8:04:21 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    CDT Equity Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure

    8-K - CDT Equity Inc. (0001896212) (Filer)

    1/2/26 4:30:46 PM ET
    $CDT
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADVM
    $APVO
    $ASML
    $ASST
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Executive Officer Staples William bought $124,750 worth of shares (3,276 units at $38.08), increasing direct ownership by 0.96% to 345,671 units (SEC Form 4)

    4 - Gitlab Inc. (0001653482) (Issuer)

    1/5/26 6:26:25 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Chief Executive Officer Weisblum Eric bought $2,075 worth of shares (5,000 units at $0.41), increasing direct ownership by 2% to 216,932 units (SEC Form 4)

    4 - Silo Pharma, Inc. (0001514183) (Issuer)

    12/16/25 6:34:59 PM ET
    $SILO
    Apparel
    Consumer Discretionary

    Chief Executive Officer Cole Matthew Ryan bought $415,999 worth of shares (515,195 units at $0.81), increasing direct ownership by 373% to 263,012 units (SEC Form 4)

    4 - Strive, Inc. (0001920406) (Issuer)

    12/16/25 9:04:18 AM ET
    $ASST
    Computer Software: Prepackaged Software
    Technology

    $ADVM
    $APVO
    $ASML
    $ASST
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    GitLab downgraded by Cantor Fitzgerald with a new price target

    Cantor Fitzgerald downgraded GitLab from Overweight to Neutral and set a new price target of $40.00

    1/7/26 8:56:37 AM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    ASML upgraded by Bernstein with a new price target

    Bernstein upgraded ASML from Mkt Perform to Outperform and set a new price target of $1,528.00

    1/5/26 8:28:55 AM ET
    $ASML
    Industrial Machinery/Components
    Technology

    Shimmick Corp. upgraded by Craig Hallum with a new price target

    Craig Hallum upgraded Shimmick Corp. from Hold to Buy and set a new price target of $6.00

    1/5/26 8:21:55 AM ET
    $SHIM
    Military/Government/Technical
    Industrials

    $ADVM
    $APVO
    $ASML
    $ASST
    Leadership Updates

    Live Leadership Updates

    View All

    GitLab Appoints Jessica Ross As Chief Financial Officer

    All Remote, GitLab Inc. (NASDAQ:GTLB), the most comprehensive, intelligent DevSecOps platform, today announced the appointment of Jessica Ross as chief financial officer, effective January 15, 2026. Ross succeeds Interim CFO James Shen, who will return to his role as vice president of finance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251202385769/en/Jessica Ross Ross' appointment comes as GitLab continues to see strong momentum, achieving 25% revenue growth in the third quarter of fiscal year 2026. She will oversee GitLab's global finance, accounting, and investor relations functions as the company accelerates DevSecOps inn

    12/2/25 4:06:00 PM ET
    $GTLB
    Computer Software: Prepackaged Software
    Technology

    Lilly to Acquire Adverum Biotechnologies

    Adverum's lead program, Ixo-vec, is a Phase 3 gene therapy designed to treat vision loss associated with wet age-related macular degeneration with a single intravitreal dose  Acquisition aligns Lilly's genetic medicine capabilities with opportunity to expand gene therapy's potential to alleviate the burden of age-related diseases  INDIANAPOLIS and REDWOOD CITY, Calif., Oct. 24, 2025 /PRNewswire/ -- Eli Lilly and Company (NYSE:LLY) and Adverum Biotechnologies, Inc. (NASDAQ:ADVM), a clinical-stage company pioneering the use of intravitreal gene therapy with the aim of preserving sight for life in highly prevalent ocular diseases, today announced a definitive agreement for Lilly to acquire Adve

    10/24/25 8:30:00 AM ET
    $ADVM
    $LLY
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Biotechnology: Pharmaceutical Preparations

    ASML appoints next Chief Technology Officer

    ASML appoints next Chief Technology Officer Marco Pieters appointed ASML Chief Technology Officer ASML Supervisory Board intends to reappoint CFO Roger Dassen and COO Frédéric Schneider-Maunoury, and to appoint CTO Marco Pieters to the Board of Management as of the April 2026 AGM VELDHOVEN, The Netherlands, October 9, 2025 – ASML Holding NV (ASML) today announced the appointment of Marco Pieters as Executive Vice President and Chief Technology Officer, reporting to President and Chief Executive Officer, Christophe Fouquet. With over 25 years of experience at ASML, most recently as Executive Vice President for the product area Applications, Pieters has a strong track record in technology l

    10/9/25 2:00:00 AM ET
    $ASML
    Industrial Machinery/Components
    Technology

    $ADVM
    $APVO
    $ASML
    $ASST
    Financials

    Live finance-specific insights

    View All

    Cineverse Acquires Giant Worldwide and Integrates Service into Matchpoint™ Platform, Bringing Deep Studio Relationships into Its Automated Media Services Ecosystem

    Acquisition Brings Giant's Existing Clients – Including the World's Top Movie Studios, Networks and Leading Entertainment Companies – to Cineverse's Matchpoint™ Ecosystem LOS ANGELES, Jan. 7, 2026 /PRNewswire/ -- Cineverse (NASDAQ:CNVS), a next-generation entertainment studio, today announced the acquisition of Giant Worldwide, a global media services provider serving the world's leading Hollywood studios and streaming platforms. Thanks to this strategic acquisition, Matchpoint™—the Company's award-winning, AI-powered media supply chain solution—solidifies its role as the lea

    1/7/26 11:00:00 AM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    CERo Therapeutics Provides Clinical Update on Phase 1 Trial of CER-1236 in AML (CertainT-1) Highlighting Key Safety Data and Platelet Transfusion–Free Interval Observed in a Patient with Myelodysplastic Syndrome/AML

    Company to host analyst call at 5:00pm ET today to discuss progress to date and expansion of clinical trial SOUTH SAN FRANCISCO, Calif, Jan. 07, 2026 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (OTCQB:CERO) ("CERo" or the "Company"), an innovative cellular immunotherapy company pursuing new targets and novel phagocytic mechanisms, announces a key clinical update from the Company's ongoing CertainT-1 trial focused on patients with acute myeloid leukemia (AML). Following completion of the dose-limiting toxicity (DLT) observation period for the first cohort, investigators observed cell expansion with no CRS, ICANS, or treatment-related adverse events reported to date. Expansion w

    1/7/26 9:09:00 AM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Hulu Acquires Streaming Rights from Cineverse for The Toxic Avenger, to Debut on the Platform January 8, 2026

    Critically Acclaimed, Fan-Favorite Action-Comedy Garnered an 86% Rotten Tomatoes Score LOS ANGELES, Jan. 6, 2026 /PRNewswire/ -- Cineverse (Nasdaq: CNVS), a next-generation entertainment studio, has announced today that streaming rights to The Toxic Avenger have been acquired by Hulu. The films SVOD premiere will be on Thursday, January 8, 2026. Photos can be found here. The Toxic Avenger received an overwhelming critical reception which praised director Macon Blair's execution along with strong performances from the all-star cast – including Peter Dinklage, Kevin Bacon (Footl

    1/6/26 12:55:00 PM ET
    $CNVS
    Consumer Electronics/Video Chains
    Consumer Discretionary

    $ADVM
    $APVO
    $ASML
    $ASST
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    12/13/24 7:18:17 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by CERo Therapeutics Holdings Inc.

    SC 13G/A - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    11/20/24 4:06:55 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form SC 13G filed by CERo Therapeutics Holdings Inc.

    SC 13G - CERO THERAPEUTICS HOLDINGS, INC. (0001870404) (Subject)

    11/20/24 4:01:41 PM ET
    $CERO
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care